サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1571847

血糖モニタリングシステムの世界市場

Blood Glucose Monitoring Systems

出版日
ページ情報
英文 92 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
血糖モニタリングシステムの世界市場
出版日: 2024年10月18日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 92 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

血糖モニタリングシステムの世界市場は2030年までに400億米ドルに達する見込み

2023年に208億米ドルと推定される血糖モニタリングシステムの世界市場は、2023年から2030年にかけてCAGR 9.8%で成長し、2030年には400億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるセルフモニタリングは、CAGR 9.3％を記録し、分析期間終了時には214億米ドルに達すると予測されます。継続的セグメントの成長率は、分析期間中CAGR 10.5％と推定されます。

米国市場は54億米ドルと推定、中国はCAGR13.0％で成長予測

米国の血糖モニタリングシステム市場は2023年に54億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに91億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは13.0%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ6.7%と7.9%と予測されています。欧州では、ドイツがCAGR約7.5%で成長すると予測されています。

世界の血糖モニタリングシステム市場- 主要動向と促進要因のまとめ

技術の進歩により血糖モニタリングシステムはどのように進化しているか？

血糖モニタリング（BGM）システム市場は、糖尿病患者にとってより正確で便利でユーザーフレンドリーな血糖モニタリングを実現する技術の進歩により、大きな進化を遂げつつあります。指を刺すテストなどの従来の血糖値モニタリング方法は、最小限の侵襲性でグルコースレベルのリアルタイム追跡を提供する持続的グルコースモニタリング（CGM）システムに取って代わられつつあります。CGMシステムは、皮下に挿入したセンサーでグルコースレベルを連続的に測定するため、患者やヘルスケアプロバイダーは、動向や変動をより正確に監視することができます。断続的モニタリングから継続的モニタリングへのこのシフトは、タイムリーな介入とより個別化された治療計画を可能にすることで、糖尿病管理を改善しています。

CGM技術と統合されたウェアラブルデバイスも人気を集めており、患者に一日中血糖値を追跡する便利で非侵襲的な方法を提供しています。これらのデバイスは多くの場合モバイルアプリに接続されており、ユーザーは自分のグルコースデータをリアルタイムで表示したり、危険な変動に関するアラートを受け取ったり、ヘルスケアプロバイダーと情報を共有したりすることができます。さらに、人工知能（AI）とデータ分析の進歩により、グルコースの変動を予測し、患者が予防措置を講じるのに役立つ予測モデリングが可能になり、血糖モニタリングシステムの精度が向上しています。

CGMシステムは糖尿病管理にどのような影響を与えるか？

持続グルコースモニタリング（CGM）システムは、グルコースレベルに関するより詳細でリアルタイムのデータを提供することで、糖尿病管理に大きな影響を与えています。一日中何度も指を刺して検査する必要がある従来の血糖測定器とは異なり、CGMシステムは継続的なデータストリームを提供するため、ユーザーはグルコースの動向やパターンを監視することができます。このリアルタイムのモニタリングにより、患者はさまざまな活動、食事、および薬剤がグルコース値にどのような影響を与えるかを特定することができ、食事、運動、およびインスリンの使用について十分な情報に基づいた決定を下すことができます。

CGMシステムはまた、グルコースレベルが高すぎたり低すぎたりした場合にアラートを送信することによって患者の安全性を高め、高血糖や低血糖の危険なエピソードを防ぐのに役立ちます。この機能は、急激なグルコース変動のリスクが高い1型糖尿病患者にとって特に有益です。CGMシステムはまた、ヘルスケアプロバイダーが長期にわたる詳細なグルコースデータにアクセスすることを可能にし、より正確な評価と治療計画の調整を可能にします。グルコースデータの質と頻度を向上させることで、CGMシステムは糖尿病ケアを変革し、世界中の何百万人もの患者の転帰を改善しています。

モバイルアプリやAIとのデータ統合はどのように血糖モニタリングを改善するのか？

モバイルアプリやAIとのデータ統合は、血糖モニタリングシステムの機能を大幅に改善し、糖尿病管理をより便利でパーソナライズされたものにしています。最近のグルコースモニターやCGMデバイスの多くはBluetooth技術を搭載し、ユーザーがグルコースレベルを追跡・管理できるスマートフォンアプリと同期できるようになっています。これらのアプリは多くの場合、ビジュアルチャート、履歴データ、傾向分析を提供し、ユーザーが長期にわたるグルコースパターンを理解するのに役立ちます。アプリの中には、食事、身体活動、投薬のログを記録し、糖尿病管理の全体像を把握できるものもあります。

AIを搭載したアルゴリズムは、過去のデータを分析し、過去の動向に基づいて将来のグルコース値を予測することで、血糖モニタリングシステムの予測機能を強化しています。これにより、患者はグルコースの急上昇や急降下を予測し、それに応じて行動やインスリン投与を調整することができます。AIはまた、リアルタイムのグルコース測定値に応じてインスリンレベルを自動的に調整する、人工膵臓システムとしても知られる閉ループインスリン送達システムの開発にも利用されています。このようなデータ統合とAIの進歩により、血糖モニタリングがよりプロアクティブになり、患者の負担が軽減され、糖尿病管理全体が改善されつつあります。

血糖モニタリングシステム市場の成長を促進する要因は？

血糖モニタリングシステム市場の成長は、世界の糖尿病有病率の増加、グルコースモニタリング技術の進歩、ウェアラブルデバイスの採用拡大など、いくつかの要因によってもたらされます。糖尿病の世界の罹患率が特に発展途上国で上昇を続ける中、患者の病状管理を支援する効果的なグルコース・モニタリング・ソリューションに対する需要が高まっています。これらのデバイスは、より正確でリアルタイムのデータを提供し、侵襲的な検査の必要性を低減するため、従来の指スティック検査から持続グルコースモニタリング（CGM）システムへのシフトは、主要な促進要因です。

CGMシステムとモバイルアプリの統合、AI、データ分析などの技術的進歩も、グルコースモニタリングをより便利に、正確に、個別化することで市場の成長を促進しています。消費者が健康管理のために非侵襲的で接続されたソリューションを好むようになっているため、ウェアラブルデバイスの人気が高まっていることも市場拡大に寄与しています。加えて、高齢化、座りがちなライフスタイルや不健康な食生活の増加が2型糖尿病の有病率増加につながり、血糖モニタリングシステムの需要をさらに促進しています。

CGMシステムに対する規制上の支援や償還政策も、特に北米や欧州などの新興国市場での採用を促進しています。ヘルスケアプロバイダーや保険会社は、糖尿病管理を改善し、糖尿病合併症に関連する長期的なコストを削減するCGMシステムの価値を認識しています。最後に、糖尿病とグルコースモニタリングの重要性に関する意識の高まりは、患者がより積極的に病状を管理し合併症を予防するようになるにつれて、これらのシステムの採用拡大につながっています。

調査対象企業の例（全36件）

  • Abbott Laboratories
  • Acon Laboratories
  • Arkray
  • Ascensia Diabetes Care
  • B. Braun Melsungen
  • Dexcom
  • F. Hoffmann-La Roche
  • Lifescan
  • Medtronic

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP21367

Global Blood Glucose Monitoring Systems Market to Reach US$40.0 Billion by 2030

The global market for Blood Glucose Monitoring Systems estimated at US$20.8 Billion in the year 2023, is expected to reach US$40.0 Billion by 2030, growing at a CAGR of 9.8% over the analysis period 2023-2030. Self-Monitoring, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$21.4 Billion by the end of the analysis period. Growth in the Continuous segment is estimated at 10.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.4 Billion While China is Forecast to Grow at 13.0% CAGR

The Blood Glucose Monitoring Systems market in the U.S. is estimated at US$5.4 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$9.1 Billion by the year 2030 trailing a CAGR of 13.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.7% and 7.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.5% CAGR.

Global Blood Glucose Monitoring Systems Market – Key Trends & Drivers Summarized

How Are Blood Glucose Monitoring Systems Evolving with Technological Advancements?

The blood glucose monitoring (BGM) systems market is undergoing significant evolution due to advancements in technology, which are making glucose monitoring more accurate, convenient, and user-friendly for patients with diabetes. Traditional methods of monitoring blood glucose levels, such as finger-prick tests, are being replaced by continuous glucose monitoring (CGM) systems that offer real-time tracking of glucose levels with minimal invasiveness. CGM systems use sensors inserted under the skin to measure glucose levels continuously, allowing patients and healthcare providers to monitor trends and fluctuations more accurately. This shift from intermittent to continuous monitoring is improving diabetes management by enabling timely interventions and more personalized treatment plans.

Wearable devices integrated with CGM technology are also gaining popularity, providing patients with a convenient, non-invasive way to track their blood glucose levels throughout the day. These devices are often connected to mobile apps, allowing users to view their glucose data in real-time, receive alerts about dangerous fluctuations, and share information with their healthcare providers. Additionally, advancements in artificial intelligence (AI) and data analytics are enhancing the accuracy of blood glucose monitoring systems by enabling predictive modeling, which can anticipate glucose fluctuations and help patients take preventive measures.

What Impact Do CGM Systems Have on Diabetes Management?

Continuous Glucose Monitoring (CGM) systems are having a profound impact on diabetes management by offering more detailed and real-time data on glucose levels, allowing patients to take proactive steps in managing their condition. Unlike traditional blood glucose meters, which require multiple finger-stick tests throughout the day, CGM systems provide a continuous stream of data, enabling users to monitor glucose trends and patterns. This real-time monitoring allows patients to identify how different activities, meals, and medications affect their glucose levels, helping them make informed decisions about their diet, exercise, and insulin use.

CGM systems also enhance safety for patients by sending alerts when glucose levels are too high or too low, helping to prevent dangerous episodes of hyperglycemia or hypoglycemia. This feature is particularly beneficial for patients with type 1 diabetes, who are at greater risk of sudden glucose fluctuations. CGM systems also enable healthcare providers to access detailed glucose data over time, allowing for more accurate assessments and adjustments to treatment plans. By improving the quality and frequency of glucose data, CGM systems are transforming diabetes care and improving outcomes for millions of patients worldwide.

How Is Data Integration with Mobile Apps and AI Improving Blood Glucose Monitoring?

Data integration with mobile apps and AI is significantly improving the functionality of blood glucose monitoring systems, making diabetes management more convenient and personalized. Many modern glucose monitors and CGM devices are now equipped with Bluetooth technology, allowing them to sync with smartphone apps where users can track and manage their glucose levels. These apps often provide visual charts, historical data, and trend analysis, helping users understand their glucose patterns over time. Some apps also allow users to log meals, physical activity, and medications, providing a holistic view of their diabetes management.

AI-powered algorithms are enhancing the predictive capabilities of blood glucose monitoring systems by analyzing historical data and predicting future glucose levels based on past trends. This can help patients anticipate glucose spikes or drops and adjust their behavior or insulin dosing accordingly. AI is also being used to develop closed-loop insulin delivery systems, also known as artificial pancreas systems, which automatically adjust insulin levels in response to real-time glucose readings. These advancements in data integration and AI are making blood glucose monitoring more proactive, reducing the burden on patients and improving overall diabetes management.

What Factors Are Driving the Growth of the Blood Glucose Monitoring Systems Market?

The growth in the blood glucose monitoring systems market is driven by several factors, including the increasing prevalence of diabetes worldwide, advancements in glucose monitoring technology, and the growing adoption of wearable devices. As the global incidence of diabetes continues to rise, particularly in developing countries, there is a growing demand for effective glucose monitoring solutions that help patients manage their condition. The shift from traditional finger-stick testing to continuous glucose monitoring (CGM) systems is a key growth driver, as these devices offer more accurate, real-time data and reduce the need for invasive testing.

Technological advancements, such as the integration of CGM systems with mobile apps, AI, and data analytics, are also driving market growth by making glucose monitoring more convenient, accurate, and personalized. The growing popularity of wearable devices is another factor contributing to the expansion of the market, as consumers increasingly prefer non-invasive, connected solutions for managing their health. In addition, the aging population and the rise in sedentary lifestyles and unhealthy diets are leading to an increased prevalence of type 2 diabetes, further fueling the demand for blood glucose monitoring systems.

Regulatory support and reimbursement policies for CGM systems are also driving adoption, particularly in developed markets such as North America and Europe. Healthcare providers and insurance companies are recognizing the value of CGM systems in improving diabetes management and reducing the long-term costs associated with diabetes complications. Finally, increasing awareness about diabetes and the importance of glucose monitoring is leading to greater adoption of these systems, as patients become more proactive in managing their condition and preventing complications.

Select Competitors (Total 36 Featured) -

  • Abbott Laboratories
  • Acon Laboratories
  • Arkray
  • Ascensia Diabetes Care
  • B. Braun Melsungen
  • Dexcom
  • F. Hoffmann-La Roche
  • Lifescan
  • Medtronic

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Blood Glucose Monitoring Systems - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Diabetes Globally Drives Demand for Blood Glucose Monitoring Systems
    • Increasing Focus on Personalized Healthcare Expands the Addressable Market for Continuous Glucose Monitoring (CGM) Systems
    • Technological Advancements in Blood Glucose Monitoring Devices Propel Growth in Accuracy and Usability
    • Growing Demand for Wearable and Non-Invasive Blood Glucose Monitoring Devices Fuels Innovation
    • Rising Awareness of Diabetes Management and Preventive Care Strengthens Market Growth for Blood Glucose Monitors
    • Integration of AI and Data Analytics in Glucose Monitoring Systems Expands Opportunities for Personalized Treatment
    • Increasing Focus on Remote Patient Monitoring and Telehealth Solutions Expands Market Adoption of Blood Glucose Monitoring Systems
    • Growing Use of Continuous Glucose Monitoring Systems in Pediatric and Geriatric Diabetes Management Drives Demand
    • Rising Adoption of Smart Insulin Pens and Automated Insulin Delivery Systems Propels Demand for Integrated Monitoring Solutions
    • Increasing Use of Blood Glucose Monitoring Systems in Hospital and Clinical Settings Expands Market Applications
    • Technological Advancements in Sensor Accuracy and Battery Life Strengthen the Business Case for Wearable Glucose Monitors
    • Rising Demand for Glucose Monitoring Apps and Digital Health Platforms Drives Adoption of Connected Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Blood Glucose Monitoring Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Blood Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Self-Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Self-Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Self-Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Continuous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Continuous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Continuous by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Fingertip Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Fingertip Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Fingertip Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Alternate Site Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Alternate Site Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Alternate Site Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Self / Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Self / Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Self / Home Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Type 1 Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Type 1 Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Type 1 Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Type 2 Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Type 2 Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Type 2 Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 28: World Blood Glucose Monitoring Systems Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • JAPAN
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • CHINA
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: China 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: China 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: China 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • EUROPE
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Blood Glucose Monitoring Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Blood Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Europe 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Europe 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • FRANCE
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 95: France Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: France 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 98: France Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: France 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: France 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 104: France Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: France Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: France 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • GERMANY
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Germany 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 110: Germany Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Germany 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 113: Germany Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Germany Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Germany 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 116: Germany Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Germany Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Germany 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 119: Italy Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Italy Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Italy 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 122: Italy Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Italy Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Italy 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 125: Italy Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Italy Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Italy 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 128: Italy Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Italy Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Italy 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 131: UK Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: UK Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: UK 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 134: UK Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: UK Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: UK 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 137: UK Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: UK Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: UK 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 140: UK Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: UK Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: UK 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 143: Spain Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Spain Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Spain 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 146: Spain Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Spain Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Spain 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 149: Spain Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Spain Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Spain 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 152: Spain Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Spain Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Spain 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 155: Russia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Russia Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Russia 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 158: Russia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Russia Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Russia 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 161: Russia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Russia Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Russia 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 164: Russia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Russia Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Russia 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 167: Rest of Europe Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Rest of Europe Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Rest of Europe 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 170: Rest of Europe Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Rest of Europe Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Rest of Europe 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Rest of Europe Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Rest of Europe 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Rest of Europe Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Rest of Europe 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 179: Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 180: Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Asia-Pacific 16-Year Perspective for Blood Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 182: Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Asia-Pacific 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Asia-Pacific 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Asia-Pacific 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Asia-Pacific 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 194: Australia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Australia Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Australia 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 197: Australia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Australia Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Australia 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 200: Australia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Australia Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Australia 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 203: Australia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Australia Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Australia 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • INDIA
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 206: India Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: India Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: India 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 209: India Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: India Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: India 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 212: India Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: India Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: India 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 215: India Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: India Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: India 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 218: South Korea Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 219: South Korea Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 220: South Korea 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 221: South Korea Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 222: South Korea Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 223: South Korea 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 224: South Korea Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 225: South Korea Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 226: South Korea 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 227: South Korea Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 228: South Korea Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 229: South Korea 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 230: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Rest of Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 232: Rest of Asia-Pacific 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 233: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Rest of Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 235: Rest of Asia-Pacific 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 236: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 237: Rest of Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 238: Rest of Asia-Pacific 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Rest of Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 241: Rest of Asia-Pacific 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 242: Latin America Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 243: Latin America Historic Review for Blood Glucose Monitoring Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 244: Latin America 16-Year Perspective for Blood Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 245: Latin America Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 246: Latin America Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 247: Latin America 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 248: Latin America Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Latin America Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 250: Latin America 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 251: Latin America Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Latin America Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 253: Latin America 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 254: Latin America Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Latin America Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 256: Latin America 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 257: Argentina Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Argentina Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 259: Argentina 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 260: Argentina Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Argentina Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 262: Argentina 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 263: Argentina Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Argentina Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 265: Argentina 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 266: Argentina Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Argentina Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 268: Argentina 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 269: Brazil Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Brazil Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 271: Brazil 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 272: Brazil Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 273: Brazil Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 274: Brazil 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 275: Brazil Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 276: Brazil Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 277: Brazil 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 278: Brazil Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 279: Brazil Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 280: Brazil 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 281: Mexico Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 282: Mexico Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 283: Mexico 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 284: Mexico Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 285: Mexico Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 286: Mexico 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 287: Mexico Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 288: Mexico Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 289: Mexico 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 290: Mexico Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 291: Mexico Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 292: Mexico 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 293: Rest of Latin America Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Rest of Latin America Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 295: Rest of Latin America 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 296: Rest of Latin America Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 297: Rest of Latin America Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 298: Rest of Latin America 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 299: Rest of Latin America Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 300: Rest of Latin America Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 301: Rest of Latin America 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 303: Rest of Latin America Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 304: Rest of Latin America 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 305: Middle East Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 306: Middle East Historic Review for Blood Glucose Monitoring Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 307: Middle East 16-Year Perspective for Blood Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 308: Middle East Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 309: Middle East Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 310: Middle East 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 311: Middle East Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 312: Middle East Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 313: Middle East 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 314: Middle East Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 315: Middle East Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 316: Middle East 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 317: Middle East Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 318: Middle East Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 319: Middle East 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 320: Iran Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 321: Iran Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 322: Iran 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 323: Iran Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 324: Iran Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 325: Iran 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 326: Iran Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 327: Iran Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 328: Iran 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 329: Iran Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 330: Iran Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 331: Iran 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 332: Israel Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 333: Israel Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 334: Israel 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 335: Israel Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 336: Israel Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 337: Israel 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 338: Israel Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 339: Israel Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 340: Israel 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 341: Israel Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 342: Israel Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 343: Israel 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 344: Saudi Arabia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 345: Saudi Arabia Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 346: Saudi Arabia 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 347: Saudi Arabia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 348: Saudi Arabia Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 349: Saudi Arabia 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 350: Saudi Arabia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 351: Saudi Arabia Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 352: Saudi Arabia 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 354: Saudi Arabia Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 355: Saudi Arabia 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 356: UAE Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 357: UAE Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 358: UAE 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 359: UAE Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 360: UAE Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 361: UAE 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 362: UAE Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 363: UAE Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 364: UAE 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 365: UAE Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 366: UAE Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 367: UAE 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 368: Rest of Middle East Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 369: Rest of Middle East Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 370: Rest of Middle East 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 371: Rest of Middle East Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 372: Rest of Middle East Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 373: Rest of Middle East 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 374: Rest of Middle East Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 375: Rest of Middle East Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 376: Rest of Middle East 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 378: Rest of Middle East Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 379: Rest of Middle East 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • AFRICA
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 380: Africa Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 381: Africa Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 382: Africa 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 383: Africa Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 384: Africa Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 385: Africa 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 386: Africa Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 387: Africa Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 388: Africa 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 389: Africa Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 390: Africa Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 391: Africa 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030

IV. COMPETITION